Vincerx Pharma, Inc.
VINCDelisted Apr 28, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796129
Vincerx Pharma, Inc. was delisted on Apr 28, 2025; its insiders filed their last Form 4 on Aug 14, 2024; 14 institutions reported holding it in 13F filings for Q1 2025, worth $116.8K in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Vincerx Pharma, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 55 | 55 | 0 |
| Shares | 15.4M | 15.4M | −44.5K (−0.3%) |
| Value | $248.9M | $156.8M | −$92.1M (−37.0%) |
New holders (9)
Institutions that held Vincerx Pharma, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Long Focus Capital Management, LLC | 140,203 | $1.43M | 0.39% |
| Clearline Capital LP | 130,856 | $1.33M | 0.18% |
| Millennium Management LLC | 53,437 | $545.0K | 0.00% |
| J. Goldman & Co LP | 43,101 | $439.0K | 0.04% |
| Nan Fung Group Holdings Ltd | 11,050 | $113.0K | 0.03% |
| Hollencrest Capital Management | 10,000 | $102.0K | 0.01% |
| Allspring Global Investments Holdings, LLC | 8,151 | $83.0K | 0.00% |
| Penserra Capital Management LLC | 2,248 | $22.0K | 0.00% |
| Point72 Hong Kong Ltd | 240 | $2.00K | 0.00% |
Sold out (9)
Institutions that held Vincerx Pharma, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Boxer Capital, LLC | 450,000 | $7.28M |
| Acuta Capital Partners, LLC | 260,000 | $4.20M |
| Monashee Investment Management LLC | 200,000 | $3.23M |
| Ikarian Capital, LLC | 199,057 | $3.22M |
| Altium Capital Management LP | 107,625 | $1.74M |
| Renaissance Technologies LLC | 30,600 | $495.0K |
| Boothbay Fund Management, LLC | 26,894 | $435.0K |
| Marshall Wace, LLP | 22,444 | $363.0K |
| TCI Wealth Advisors, Inc. | 60 | $1.00K |